The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Hantavirus-hit Ship Sets Sail for Netherlands as Final Passengers Evacuated in Tenerife

The hantavirus-hit MV Hondius departed the Spanish island of Tenerife for the Netherlands on Monday as the last six passengers and some crew members were evacuated from the...

Germany Monitors Four Hantavirus Contacts in Frankfurt

Four German contacts from the hantavirus-hit cruise ship are being monitored in a special isolation unit at Frankfurt University Hospital ⁠after arriving overnight.

US Says 18 Passengers Flown Back After Hantavirus Outbreak on Ship

U.S. Department of Health and Human Services officials said on Monday that 18 passengers from the luxury cruise ship hit by a hantavirus outbreak were flown back to the...

Hantavirus Protocol Breach At Dutch Hospital as Medics Race to Curb Spread

A Dutch hospital has quarantined 12 staff members as a preventive measure after blood and urine from a hantavirus patient were handled without observing strict protocols, as...

CMS Wants Healthier Hospital Food, But Patient Needs Vary

Federal agency wants hospitals to more closely follow new Dietary Guidelines for Americans.

26-Year-Old Man With Posttransfusion Hyperhemolysis

Severe posttransfusion hyperhemolysis in a sickle cell patient produced profound anemia and lactic acidosis; terminal complement blockade with eculizumab stabilized hemolysis and enabled recovery.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

The hantavirus-hit MV Hondius departed the Spanish island of Tenerife for the Netherlands on Monday as the last six passengers and some crew members were evacuated from the...

Four German contacts from the hantavirus-hit cruise ship are being monitored in a special isolation unit at Frankfurt University Hospital ⁠after arriving overnight.

U.S. Department of Health and Human Services officials said on Monday that 18 passengers from the luxury cruise ship hit by a hantavirus outbreak were flown back to the...

A Dutch hospital has quarantined 12 staff members as a preventive measure after blood and urine from a hantavirus patient were handled without observing strict protocols, as...

Federal agency wants hospitals to more closely follow new Dietary Guidelines for Americans.

Severe posttransfusion hyperhemolysis in a sickle cell patient produced profound anemia and lactic acidosis; terminal complement blockade with eculizumab stabilized hemolysis and enabled recovery.

News All Time

New Paper Highlights Evidence for Congenital Lyme Disease

Evidence suggests Borrelia burgdorferi can cross the placenta and may be associated with adverse pregnancy outcomes.

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Optimizing COVID-19 Care for Hospitalized Patients

Optimizing COVID-19 Care for Hospitalized Patients

International Perspectives on Individualizing Care for Hospitalized Patients With COVID-19

International Perspectives on Individualizing Care for Hospitalized Patients With COVID-19

Procalcitonin-Guided Sepsis Care Improves Survival, Had No Effect on Antibiotic Use

Clinicians agreed with the algorithm's recommendation in 47% of cases

In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

Results of lung impedance-guided therapy in HFpEF also anticipated this weekend

Ceragenin-Coated Endotracheal Tubes Fail to Reduce Ventilator-Associated Pneumonia

Intervention was tied to other improvements versus standard ETTs

Bedside Classification of ARDS Subtype May Help Spot Patients With Higher Death Risk

Study advances precision medicine, expert says

Watchman LAA Occluder Bounces Back as Alternative to OAC in CHAMPION-AF

Study suggests a path forward for device therapy, though caveats are plenty

Impella Flops for Acute Coronary Syndrome Patients Not in Shock

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusion delay

Endotoxin Removal Tied to Lower Mortality Risk in Septic Shock Subtype

Trial findings represent a step toward precision medicine in sepsis

Drop the Beta-Blocker Long After a Stabilized MI? Not a Bad Idea After All

Trial assessed outcomes of quitting therapy after 1 year among select MI survivors

An Unusual Case of Pneumonia on 'The Pitt': An Emergency Doctor Weighs In

MedPage Today's Jeremy Faust looks at how closely Episode 4 of Season 2 reflects real-world care

Therapy Linked to Lower Death Risk in Serious Tick-Borne Illness

The incidence of babesiosis, which infects red blood cells, is increasing

More Heart Failure Patients Could Benefit From Lung Impedance Monitoring

Trial shows fewer HF hospitalizations in HFpEF

Virtual Neuro Rounds Better Than On-Site Consults in Subacute Stroke Care

Noninferiority study meets criteria for superiority

Recommended News For You

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

Studies point to redlining as a 'perfect storm' for breast cancer

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

The response of bipolar patients to lithium may be predicted by ancestry.

O. A. J. Simpson passes away from cancer.

Waiting for a Sharp Increase in Prostate Cancer Cases.

Recommended Articles For You

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown 

Obesity is a major risk factor for cancer 

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy 

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Positive Survival Data in Lung Cancer With Perioperative Therapy

2.

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

3.

Sickle Cell Disease Drug Pulled From Global Markets

4.

Biomarker panel offers hope for early pancreatic cancer detection

5.

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

1.

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition

2.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

3.

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia

4.

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v

5.

Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot